Exploring the views of female genital mutilation survivors, their male partners and healthcare professionals on the timing of deinfibulation surgery and NHS FGM care provision (the FGM Sister Study): protocol for a qualitative study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 10 2019
Historique:
entrez: 20 10 2019
pubmed: 20 10 2019
medline: 31 10 2020
Statut: epublish

Résumé

Female genital mutilation (FGM) is a significant global health concern and is likely to become an increasingly important healthcare challenge in destination countries such as the UK owing to rising levels of migration from FGM-affected countries. Currently, there is no consensus on the optimal timing of deinfibulation (opening) surgery for women who have experienced type 3 FGM and care provision remains suboptimal in the UK. This qualitative study aims to explore the views of survivors, male partners and healthcare professionals (HCPs) on the timing of deinfibulation and delivery of NHS FGM services. A qualitative study, informed by the Sound of Silence conceptual framework, will be undertaken via two work packages (WPs). WP1 will explore views on timing preferences for deinfibulation and NHS FGM services through interviews and discussion groups with FGM survivors (n~50), male partners (n~10) and HCPs (n~50). WP2 will use established techniques via two workshops (community (n~20-25 participants) and national stakeholder (n~30-35 participants)) to synthesise qualitative research findings and inform best practice and policy recommendations around the timing of deinfibulation and NHS FGM care provision. Supported by trained interpreters, data collection will be audio recorded and transcribed. Data will be analysed using the framework method to facilitate a systematic mapping and exploration of qualitative data from multiple sources. The study has received ethical approval from the North West Greater Manchester East Research Ethics Committee (18/NW/0498). The outputs for this study will be recommendations for best practice and policy around FGM care provision that reflects the views and preferences of key stakeholders. The findings will be disseminated via conference presentations, peer-reviewed publications, patient groups, third sector organisations and social media. ISRCTN 14710507.

Identifiants

pubmed: 31628134
pii: bmjopen-2019-034140
doi: 10.1136/bmjopen-2019-034140
pmc: PMC6803147
doi:

Banques de données

ISRCTN
['ISRCTN14710507']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034140

Subventions

Organisme : Department of Health
ID : HTA/16/78/04
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Glob Health Action. 2016 Oct 04;9:31489
pubmed: 27707452
Arch Gynecol Obstet. 2013 Jun;287(6):1137-49
pubmed: 23315098
BMJ. 1995 Jul 29;311(7000):299-302
pubmed: 7633241
Midwifery. 2013 Feb;29(2):154-8
pubmed: 23084491
Int J Gynaecol Obstet. 2017 Feb;136 Suppl 1:21-29
pubmed: 28164285
Med Educ. 2006 Apr;40(4):314-21
pubmed: 16573666
BMJ Open. 2014 Nov 21;4(11):e006316
pubmed: 25416059
BJOG. 2015 Feb;122(3):294-303
pubmed: 25514892
BMJ Open. 2019 May 29;9(5):e027452
pubmed: 31147364
Obstet Gynecol Int. 2013;2013:496564
pubmed: 23878544
BJPsych Bull. 2015 Dec;39(6):273-7
pubmed: 26755984
Afr J Reprod Health. 2007 Apr;11(1):33-42
pubmed: 17982946
Int J Gynaecol Obstet. 2017 Feb;136 Suppl 1:3-12
pubmed: 28164287
J Adv Nurs. 2006 Dec;56(5):491-7
pubmed: 17078825
Cult Health Sex. 2005 Sep-Oct;7(5):443-61
pubmed: 16864215
Int J Gynaecol Obstet. 2017 Feb;136 Suppl 1:30-33
pubmed: 28164295
Lancet. 2006 Jun 3;367(9525):1835-41
pubmed: 16753486
Int J Gynaecol Obstet. 2017 Feb;136 Suppl 1:43-46
pubmed: 28164291
Int J Gynaecol Obstet. 2017 Feb;136 Suppl 1:13-20
pubmed: 28164296
Bull World Health Organ. 2010 Apr;88(4):281-8
pubmed: 20431792
Nurs Health Sci. 2010 Sep 1;12(3):369-74
pubmed: 20727089
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Midwifery. 2014 Mar;30(3):282-8
pubmed: 23747293
Med Anthropol Q. 1999 Mar;13(1):79-106
pubmed: 10322603
Curr Pharm Teach Learn. 2018 Jun;10(6):807-815
pubmed: 30025784

Auteurs

Laura Jones (L)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK L.L.Jones@bham.ac.uk.

Emma Danks (E)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Joanne Clarke (J)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Lailah Alidu (L)

Warwick Medical School, University of Warwick, Warwick, UK.

Benjamin Costello (B)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Kate Jolly (K)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Alison Byrne (A)

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Meg Fassam-Wright (M)

National FGM Centre, Barnardo's, Ilford, Essex, UK.

Pallavi Latthe (P)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Julie Taylor (J)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
School of Nursing, University of Birmingham, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH